Abstract
BACKGROUND AND PURPOSE: High-resolution carotid MR imaging can accurately identify complicated American Heart Association lesion type VI plaques, which are characterized by thrombus, hemorrhage, or a ruptured fibrous cap. The purpose of this study is to evaluate whether CTA can be used as screening tool to predict the presence or absence of American Heart Association lesion type VI plaques as defined by high-resolution MR imaging.
METHODS: Fifty-one patients with suspected ischemic stroke or TIA with carotid CTA and carotid MR imaging performed within 14 days of the event/admission from April 2008 to December 2010 were reviewed. Vessels with stents or occlusion were excluded (n = 2). Each carotid artery was assigned an American Heart Association lesion type classification by MR imaging. The maximum wall thickness, maximum soft plaque component thickness, maximum calcified component thickness, and its attenuation (if the soft plaque component thickness was >2 mm) were obtained from the CTA.
RESULTS: The maximum soft plaque component thickness proved the best discriminating factor to predict a complicated plaque by MR imaging, with a receiver operating characteristic area under the curve of 0.89. The optimal sensitivity and specificity for detection of complicated plaque by MR imaging was achieved with a soft plaque component thickness threshold of 4.4 mm (sensitivity, 0.65; specificity, 0.94; positive predictive value, 0.75; and negative predictive value, 0.9). No complicated plaque had a soft tissue plaque thickness <2.2 mm (negative predictive value, 1) and no simple (noncomplicated) plaque had a thickness >5.6 mm (positive predictive value, 1).
CONCLUSIONS: Maximum soft plaque component thickness as measured by carotid CTA is a reliable indicator of a complicated plaque, with a threshold of 2.2 mm representing little to no probability of a complicated American Heart Association lesion type VI plaque.
ABBREVIATIONS:
- AHA-LT6
- American Heart Association type VI
- IPH
- intraplaque hemorrhage
- HU
- Hounsfield units
Macroangiopathic disease causes 20–30% of ischemic strokes, most occurring as the result of plaque rupture.1,2 This percentage might even be higher, as a recent MR imaging study3 suggested that a substantial portion of patients with cryptogenic strokes have ipsilateral complicated American Heart Association type VI (AHA-LT6) carotid plaques, characterized by intraplaque hemorrhage (IPH), thrombus, or a ruptured fibrous cap. These characteristics are currently identifiable on high-resolution MR imaging of the carotid arteries4,5 with improved sensitivity and specificity with the use of specialized high-resolution techniques.4,6⇓⇓–9 Furthermore, several MR studies have demonstrated that AHA-LT6 plaques are related to increased risk of stroke independent of the severity of luminal stenosis.10,11 High-resolution MR imaging of the carotid bifurcation, however, is time-consuming, requires specialized coils, and is not widely available.
Carotid sonography is often used as a first-line imaging technique to screen for the presence or absence of atherosclerosis, but this method is highly operator-dependent and provides limited information regarding plaque morphology and complications.12⇓–14 Operators usually focus on the degree of stenosis, and intima-media thickness measurements, plaque thickness, and morphology are not considered part of the routine sonography evaluation.
CT of the brain is commonly used as part of the routine clinical work-up in patients with suspected ischemic stroke or TIA. CTA of the circle of Willis and cervical carotid arteries is frequently performed concomitantly to evaluate for thrombus and to define the degree of carotid stenosis,15 which is the only broadly accepted finding used to indicate endarterectomy.16⇓–18 Furthermore, carotid CTA provides high-resolution images of the carotid bulb to identify ulcerations19⇓–21 and it also provides information about aortic arch plaques, which have been associated with thromboembolic events.22
MDCT angiography is also able to differentiate between soft, mixed, and hard plaques, with questionable evaluation of fibrous tissue and lipid-rich necrotic core.23⇓–25 The use of Hounsfield units (HU) analysis for the identification of the components is limited secondary to overlap in HU values between different plaque components and the presence of artifacts from calcified plaque and the enhanced arterial lumen.26,27 To date, CTA is not able to reliably identify complicated AHA-TL6 plaques, which are characterized by fibrous cap rupture, attached thrombus, or hemorrhage, and are the imaging findings most closely related with an increased clinical risk of stroke.11 Thus, it would be beneficial to evaluate imaging characteristics found on CTA that would warrant obtaining a high-resolution MR imaging of the carotid bifurcation.
The purpose of this study is to evaluate whether carotid CTA can be used as a screening tool to predict the presence or absence of a complicated AHA-LT6 carotid bulb plaque with fibrous cap rupture, attached thrombus, or hemorrhage as defined by high-resolution MR imaging.
Materials and Methods
Patient Selection
Patients with suspected ischemic stroke or TIA of the anterior circulation who had a carotid CTA and high-resolution carotid MR imaging performed within 14 days of the event or admission from April 2008 to December 2010 were included. Patients with imaging studies of insufficient quality and vessels with prior endarterectomy, stent, or occlusion were excluded. The study was approved by the local ethics committee, and all subjects gave written informed consent. CT brain imaging was routinely performed immediately after presentation to assess intracerebral hemorrhage and acute ischemic stroke.
Imaging Protocols and Analysis
Because assessment of patients with stroke is performed by several units in our clinical center, scans were performed on various CT scanners: Bright Speed S (GE Healthcare, Milwaukee, Wisconsin), Aquilion (Toshiba Medical Systems, Tokyo, Japan), Somatom Definition Flash (Siemens, Erlangen, Germany), Somatom Definitition AS+ (Siemens), and Sensation 64 (Siemens). All CTA images were obtained with coverage at least from the aortic arch to the cranium by use of the respective standard protocol parameters. Nonionic iodinated contrast material was applied intravenously, adjusted to patient weight (Ultravist 370; BayerSchering Pharma, Berlin, Germany, ie, 0.35–0.50 g iodine per kg body weight at an injection rate of 4.5–6 mL/s followed by 100 mL of saline at identical flow) (On-line Table).
Participants underwent high-resolution black-blood carotid MR imaging within a mean of 7.8 days after the CT scan. All subjects were imaged by use of a previously published multisequence protocol24 (TOF MR angiography, axial precontrast and postcontrast black-blood T1, proton attenuation, and T2WI sequences with fat saturation centered at the carotid bifurcation; best in-plane resolution, 0.5 × 0.5 mm2) at 3T (Magnetom Verio, Siemens). To improve signal-to-noise performance and optimize spatial resolution, a dedicated 4-channel surface coil (Machnet B.V., Eelde, The Netherlands) was used for bilateral carotid scans. Gadolinium-DO3A-Butrol (Gadobutrol, Bayer Schering) of 0.1 mmol/kg (0.1 mL/kg) was given at a rate of 3 mL/s.
An experienced radiologist blinded to the MR imaging results (M.T.) reviewed the axial sections of the CTAs to obtain the following measurements: maximum plaque wall thickness, maximum thickness of soft plaque component, and maximum thickness of calcified plaque component (On-line Figure). If the soft plaque component thickness was >2 mm, 2 oval ROIs were obtained from the plaque area measuring the mean, minimum, and maximum HU and the standard deviation. Window level settings were set at 800/200, though small adjustments were allowed. The ROI size was kept ≥2 mm2. Superimposition of both ROIs was allowed in cases with small plaques. The ROIs were taken with care to include the area showing less attenuation, avoiding calcifications and the enhanced lumen. The presence of ulceration or thrombus was also noted. Ulcerations were defined as an outpouching of contrast material >1 mm.28 For completeness, the percentage of stenosis obtained by the NASCET method was also calculated.
To assess for the reproducibility of the axial measurements, a second experienced radiologist (K.M.E.) who was blinded to the initial results repeated the measurements in the original axial sections in 20 patients (40 carotid arteries). Furthermore, to explore the potential of measurements in a plane orthogonal to the lumen and to exclude a systematic bias of the axial measurements, curved planar reformatted images of the same 20 patients were uploaded in a separate session on a dedicated workstation (IMPAX Volume Viewing 2.2; Agfa, Greenville, South Carolina) and all plaque thickness measurements were repeated in an orthogonal plane. An image-quality rating (4-point scale, 1 = nondiagnostic, 2 = moderate, 3 = good, 4 = excellent) was assigned to all MR images. The MR imaging data were classified according to the modified American Heart Association lesion type classification as previously defined by Cai et al29 by 2 experienced radiologists (T.S. and K.N.) who were blinded to the CTA data. In the case of discrepancy, a consensus decision was made. Patients with image quality ≥2 by MR imaging were included. The presence of complications such as hemorrhage, fibrous cap rupture, ulceration, calcific nodule, or thrombus was also annotated.
Statistical Analysis
Categoric variables are presented as percentages; continuous variables are presented as mean ±95% confidence interval. Data analysis was performed by use of SPSS Statistics (Version 20; IBM, Armonk, New York). Graphs were constructing with the use of Excel (Version 14; Microsoft, Redmond, Washington). Continuous data were compared with the unpaired Student t test. Categoric data were compared by means of χ2 test. Inter-reader and intermeasurement agreement (between measurements in the axial plane and a plane orthogonal to the vessel lumen) was determined by the intraclass correlation coefficient. A value of P < .05 was considered statistically significant. Receiver operating characteristic curves were constructed to evaluate the ability of the different imaging characteristics to predict the presence of complicated plaque by MR imaging. The optimal sensitivity and specificity were calculated together with the area under the curve.
Results
Patients
Fifty-four patients were included (mean age of 71 years, male/female ratio of 2.9/1). Three MR imaging scans (with 6 carotid vessels in total) were excluded because of insufficient image quality. One carotid vessel with a stent and 1 carotid vessel with total occlusion were also excluded. This resulted in a total of 100 carotid vessels in 51 patients for analysis. Patient information is shown in Table 1.
Patient characteristics
Carotid Plaque Lesion Type Classification
Twenty-three carotid arteries had a complicated AHA-LT6 by MR imaging, with the presence of IPH, thrombus, or a ruptured fibrous cap. Seven arteries were classified as type I, 14 as type III, 38 as type IV/V, and 18 as type VII plaques. No plaque was classified as a type VIII plaque; 67 of 100 vessels had a maximum thickness plaque component >2 mm and thus HU measurements were performed. All of the complicated plaques had a soft plaque thickness >2 mm and thus HU was measured.
Table 2 and Fig 1 show the CTA-based plaque characteristics average results for the maximum plaque wall thickness, maximum thickness of soft plaque component, and maximum thickness of calcified plaque component as well as the average HU for the mean, maximum, and minimum densities and the average NASCET percentage stenosis according to the MR imaging–based assessment of the AHA lesion type. Confidence intervals are also reported. In general, maximum thickness and maximum soft plaque thickness increased from type I/II to type VI lesions and slightly decreased in type VII lesions, which are predominantly calcified. Therefore, the hard plaque component was largest in type VII lesions. Densities of the plaques were lower in the plaques with a lipid-rich necrotic core by MR imaging such as type IV/V and type VI compared with the lesions that were classified as predominantly fibrous by MR imaging, such as type III lesions or the soft component of type VII lesions (P = .02). The average percentage of stenosis also increased from type I/II (nonstenotic), reaching a maximum with AHA-LT6. Lesion type VII showed a slight decrease in average percentage stenosis compared with AHA-LT6.
General plaque characteristics by MRI-derived AHA lesion type
General plaque characteristics by MR imaging–derived American Heart Association lesion type. Thickness is given in centimeters, density in Hounsfield units, stenosis in percentage (%) ± confidence interval.
Table 3 compares complicated (AHA LT-6) and noncomplicated plaques. The average maximum thickness of the soft plaque component, the average maximum wall thickness, the NASCET percentage stenosis, and presence of ulcerations were significantly higher in complicated plaques compared with noncomplicated plaques (4.7 ± 0.5 versus 2.2 ± 0.3 mm, P < .001; 5.3 ± 0.4 versus 3.9 ± 0.3 mm, P < .001; 46.3% ± 10.6% versus 20.5% ± 6.0%, P < .001; and 15.8% ± 19.5% versus 34.8% ± 7.8%, P = .02, respectively). The mean the soft plaque component attenuation did not differ significantly between complicated and noncomplicated plaques (60 ± 12 versus 72 ± 12 HU, P = .12).
General plaque characteristics of noncomplicated versus complicated AHA-LT6 by MRI
The maximum soft plaque thickness was the best single discriminating factor to predict a complicated plaque by MR imaging, with a relative receiver operating characteristic area under the curve of 0.90 ± 0.06. Maximum wall thickness, NASCET percentage stenosis, and presence of ulceration performed less adequately with receiver operating characteristic area under the curve of 0.81 ± 0.08, 0.76 ± 0.11, and 0.60 ± 0.14, respectively. Hard plaque component thickness and HU measurements were not of diagnostic help. Utilization of maximum, minimum, and average HU values made no difference in the discriminatory power. Fig 2 shows these multiple receiver operating characteristic curves. Although the presence of ulceration showed a statistically significant relationship with the presence of complicated AHA-LT6 plaques, it performed poorly from a clinical standpoint (sensitivity, 0.35; specificity, 0.86; positive predictive value, 0.42; and negative predictive value, 0.81).
Receiver operating characteristic curves for the performance of the maximum wall thickness, maximum soft plaque thickness, maximum hard plaque thickness, mean attenuation NASCET percentage stenosis values, and presence of ulceration in screening for complicated AHA-LT6 plaques (area under the curve, 0.810 ± 0.084, 0.897 ± 0.063, 0.433 ± 0.123, 0.384 ± 0.155, 0.756 ± 0.106, and 0.602 ± 0.139, respectively).
Figs 3 and 4 show MR and CTA images of 2 complicated AHA-LT6 plaques by MR imaging. Although CTA images show plaques with distinct densities (16 versus 54 HU), MR imaging identifies IPH in both lesions representing complicated AHA-LT6 plaques.
CTA image through a complicated AHA-LT6 plaque in the right carotid artery at the carotid bifurcation shows a soft plaque with a mean attenuation of 16 HU (range, −7 to 46) and a thickness of the soft plaque component of 6 mm. TOF, T1, T2, and T1 postgadolinium images at the same level show a hyperintense plaque on all 4 weightings, which suggests the presence of type II IPH.
TOF, T1, T2, and T1 postgadolinium images of a complicated AHA-LT6 plaque in the left internal carotid artery. The plaque is hyperintense on TOF and T1WI and hypointense on T2WI, which suggests the presence of type I IPH. The CT image at the identical location shows a high attenuation soft plaque with a mean attenuation of 51 HU (range, 29–144) and a thickness of the soft plaque component of 8 mm.
Optimal sensitivity and specificity for detection of complicated plaque by MR imaging was achieved with a soft plaque component thickness threshold of 4.4 mm (sensitivity, 0.65; specificity, 0.94; positive predictive value, 0.75; and negative predictive value, 0.9). Furthermore, of the 42 arteries with a soft plaque thickness <2.2 mm, no complicated AHA-LT6 plaque was identified by MR imaging (negative predictive value, 1), and of the 5 arteries with a soft plaque thickness >5.6 mm all plaques were complicated AHA-LT6 plaques (positive predictive value, 1).
Interreader and Intermeasurement Agreement
The interreader intraclass correlation coefficient between reviewers 1 and 2 for axial measurements was 0.94 (0.89–0.97), 0.64 (0.48–0.83), and 0.95 (0.91–0.98) for the measurements of maximum plaque wall thickness, maximum thickness of calcified plaque component, and maximum thickness of soft plaque component (Table 4). When axial measurements were compared with measurements obtained at an orthogonal plane to the lumen, the intraclass correlation coefficients were 0.86 (0.75–0.92), 0.80 (0.64–0.89), and 0.93 (0.87–0.96) for reader 1 and 0.93 (0.87–0.96), 0.69 (0.47–0.82), and 0.97 (0.94–0.98) for reader 2.
Interreader and intermeasurement intraclass correlation coefficients for maximum wall, calcified plaque, and soft plaque thickness
Discussion
The current study demonstrates that an easy-to-obtain CTA measurement, the maximum width of the soft tissue component of the atherosclerotic plaque on CTA images, is well suited to screen for the presence of complicated AHA-LT6 plaques. The optimal sensitivity and specificity for detection of complicated plaque by MR imaging was achieved with a soft plaque component thickness threshold of 4.4 mm. More importantly, no plaque with a soft plaque component thickness <2.2 mm showed signs of complication by MR imaging. Thus, this easy-to-obtain parameter may be used to screen for the presence of complicated AHA-LT6. Furthermore, all arteries with a soft plaque thickness >5.6 mm were complicated AHA-LT6 plaques, which suggests that this plaque thickness is a good indicator for the presence of complicated atherosclerotic lesions.
Recent studies have shown a strong correlation between the maximal wall thickness and risk for new carotid stroke.30,31 This correlation could—at least in part—be explained by findings from our study, which suggest a strong correlation of all thickness measurements and presence of complicated AHA-LT6. This is also consistent with previous CTA studies that suggested a strong correlation between volumetric size of the soft plaque component and presence of ulceration28 and between presence of ulceration and IPH as described by MR imaging.26 However, we also showed that the maximum thickness of the soft plaque component performed better than the above-mentioned imaging characteristics in the prediction of a complicated AHA-LT6 plaque by MR imaging. This study reinforces that complications occur in the soft plaque component of the atherosclerotic plaque, and it can be assumed that the probability of finding a complication increases with the size of the soft plaque thickness.
A previous CTA/MR imaging comparison study showed that the attenuation of plaques with IPH is larger than the attenuation of plaques without IPH (47 versus 43 HU, P = .02).26 However, this study found a large overlap of HU of plaques with and without IPH, which suggests that HU measurements are not suited to identify complicated plaques. These findings are supported by our study, which did not show any significant differences in HU of complicated and noncomplicated plaques. Initially we had hypothesized that with the use of the minimal HU value obtained from the ROIs, we would be able to better differentiate hemorrhagic from lipid-rich necrotic core lesions; however, that was not supported by our data.
Interestingly, when all the lesion types containing a lipid-rich necrotic core were combined, those lesions had a significantly lower attenuation than lesions with predominantly fibrous tissue, such as lesion type III and the soft component of lesion type VII (P = .02). This is consistent with a previous study by de Weert et al,23 which showed that CT is able to differentiate lipid from fibrous tissue if lesions are not calcified. Although our study showed that CTA is able to differentiate between lipid and fibrous tissue in noncomplicated plaques, our findings also indicated that CTA is unable to differentiate between lipid-rich lesions with and without complications, thus limiting its clinical use to identify the vulnerable plaque.
Interreader agreement for the maximum soft plaque component thickness and maximum total vessel wall thickness was excellent, which indicates that these measurements are highly reproducible. Although orthogonal vessel wall measurements are generally considered more accurate than axial measurements because they are not biased by vessel tortuosity, our results indicate excellent agreement between measurements in axial and orthogonal planes and no systematic difference. In our opinion, axial thickness measurements are preferable because they are less time-consuming and can be performed easily without postprocessing on a standard PACs work station. Thus, this measurement can be easily adopted into routine clinical practice.
Limitations
Our patient population had a relatively large percentage of complicated plaques (23%). However, this is expected because all patients had a symptomatic TIA or ischemic stroke of the anterior circulation, and strong associations between AHA-LT6 and ischemic stroke have been reported recently.11 Although efforts were made to reduce the time between studies, delay in obtaining the MR imaging may have generated confounding variables. However, on the basis of our experience and the experience of others with serial MR imaging, atherosclerotic changes over time are minimal.10,32 We do not believe that this altered our results substantially. Of importance, in our clinic, patients with CTA-proven or sonography-proven significant carotid stenosis of >70% undergo carotid intervention within 24 hours and were thus excluded from our study.
Conclusions
The maximum soft plaque component thickness as measured by carotid CTA has the best discriminatory power to predict the presence or absence of AHA-LT6. All plaques with a soft tissue component >5.6 mm were associated with complicated AHA-LT6 by MR imaging, whereas none of the plaques with a soft tissue component <2.2 mm showed a complicated AHA-LT6. Thus, 2.2-mm soft plaque thickness appears to be the ideal cutoff to exclude the presence of complicated AHA-LT6 plaque, though further studies are needed to confirm the reliability of the above stated thresholds. Of particular importance is to confirm that a larger soft plaque component size increases the probability of atherosclerotic plaque complications and thus the probability of clinical strokes.
Footnotes
Disclosures: Martin Dichgans—UNRELATED: Board Membership: Boehringer Ingelheim, EVER Pharma; Consultancy: Bayer, Boehringer Ingelheim, Heel, Bristol-Myers-Squibb; Grants/Grants Pending: EU FP7,* DFG,* DLR,* Fondation Leducq,* Vasc.Dem.Res.Found.,* Jackstaedt,* Corona*; Payment for Manuscript Preparation: Georg Thieme, UpToDate, W. Kohlhammer. Tobias Saam—UNRELATED: Grants/Grants Pending: Deutsche Forschungsgemeinschaft (EXC158),* Comments: “Grating-Based Phase Contrast Applied to Atherosclerotic Plaque Imaging using Compact X-Ray Sources”; Payment for Lectures (including service on speakers bureaus): MSD Sharp, DOHME Gmbh, GlaxoSmithKline (*money paid to institution).
REFERENCES
- Received December 6, 2012.
- Accepted after revision March 20, 2013.
- © 2013 by American Journal of Neuroradiology
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.